At Genet, we offer the “Oncomine Tumor Mutation Load Assay,” a cutting-edge service designed to identify cancer driver variants and evaluate tumor mutational burden (TMB), a promising immuno-oncology biomarker, utilizing next-generation sequencing technology. Immune checkpoint […]
The following targets are included in the Oncomine™ HRR Pathway Predesigned Panel:
Transcriptome Human Gene Expression RNA Human Oncology Pathways RNA Breast Cancer Research Panel RNA Cancer Panel RNA Pancreatic Adenocarcinoma Research Panel RNA MAPK Pathway Research Panel Long Non-coding RNA Research Panel RNA WNT Signaling Pathway […]
@ Genet Canada Corporation | Website content is for educational and research purposes only and is not intended to be used for medical advice, diagnosis or treatment.